GlassScriptPhysician profile
Shane T Prettyman
NPI 1861695421
$1,093.58
in general payments reported to CMS, 2019-2025
20 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $52.97 · 2021: $64.67 · 2022: $377 · 2023: $126 · 2024: $129 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $293.55 | 2022-2025 | |
| Organon LLC | $105.71 | 2022-2025 | Jada System, Nexplanon, Nuvaring |
| Shield Therapeutics INC | $98.44 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.32 | 2022-2025 | |
| Abbvie INC. | $67.33 | 2019-2022 | |
| Conmed Corporation | $66.67 | 2022 | |
| Roche Diagnostics Corporation | $55.46 | 2019-2020 | |
| Coopersurgical, INC. | $54.50 | 2020-2021 | |
| Sage Therapeutics, LLC | $53.28 | 2025 | Zurzuvae |
| Allergan, INC. | $32.12 | 2019 | |
| Axonics, INC. | $26.37 | 2023 | Axonics |
| Medtronic, INC. | $24.53 | 2022 | |
| Therapeuticsmd, INC. | $21.18 | 2021 | |
| Astellas Pharma US INC | $20.79 | 2023 | Veozah |
| Supernus Pharmaceuticals, INC. | $18.85 | 2025 | Qelbree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.52 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $14.02 | 2022 | |
| Hologic Sales and Service, LLC | $13.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.12 | 2019 | |
| Acessa Health INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Prettyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.